The prevalence of total shoulder arthroplasty (TSA) in the United States has increased significantly, with an estimated 29,414 to 34,550 procedures performed from 2011 to 2014.^[@bibr9-2325967120932106],[@bibr33-2325967120932106]^ Outcomes after TSA have been promising, with reported implant survival rates of 93% at 10 years and 87% at 15 years as well as patient satisfaction only declining from 92% to 83% over the long term.^[@bibr37-2325967120932106]^

However, intraoperative and postoperative complications remain a common challenge, reportedly occurring in 5.4% and 7.8% of cases, respectively.^[@bibr27-2325967120932106]^ The most frequently reported long-term complication of TSA is glenoid loosening, accounting for approximately 24% of all TSA complications.^[@bibr15-2325967120932106]^ The cause of glenoid loosening is likely multifactorial and may be related to surgical technique, implant design, patient characteristics, rotator cuff integrity, or the presence of indolent infections.^[@bibr15-2325967120932106]^ As radiolucency of glenoid components at 10-year follow-up has been shown to occur more frequently in the patients' dominant extremity compared with the nondominant side, handedness of the patient may be an additional risk factor.^[@bibr5-2325967120932106]^ Additionally, the influence of surgeon upper extremity dominance in TSA and whether outcomes vary among patients undergoing right or left TSA with respect to surgeon handedness have yet to be investigated. Further, it remains unknown whether patients undergoing TSA on their dominant arm have better clinical outcomes compared with their nondominant arm. This is an important consideration, given the preferential use of the dominant extremity exhibited by most patients during activities of daily living.

Operating on a right shoulder might be technically more demanding for a right-handed surgeon and vice versa, as it is considered in total knee arthroplasty.^[@bibr26-2325967120932106]^ This effect of surgeon handedness on operative psychomotor performance has already been investigated in other subspecialties.^[@bibr3-2325967120932106],[@bibr17-2325967120932106],[@bibr19-2325967120932106],[@bibr30-2325967120932106],[@bibr35-2325967120932106]^ Even in the field of orthopaedic surgery, there have been significant differences in function and pain scores after total knee arthroplasty, based on which knee was undergoing surgery performed by a right-handed surgeon.^[@bibr26-2325967120932106]^ Thus, the purpose of this study was to determine if patient or surgeon upper extremity dominance has an effect on clinical outcomes after primary TSA. We hypothesized that for TSA performed on right-handed patients by a right-handed surgeon, short-term clinical outcomes would be significantly poorer when compared with the left side. Additionally, patients who underwent TSA on their nondominant side would have superior short-term clinical outcomes when compared to the dominant side.

Methods {#section1-2325967120932106}
=======

Institutional review board approval was obtained before the initiation of the study. This is a retrospective case series of prospectively collected data between June 2008 and August 2012 from the practice at a single institution of 1 senior surgeon (A.D.M.; a fellowship-trained, academic orthopaedic surgeon who has been in practice for 6 years at the time of data collection). The senior surgeon (A.D.M.) was right-hand dominant. Inclusion criteria included patients with glenohumeral arthritis who had failed previous nonoperative treatment. All patients were required to have an intact rotator cuff, be healthy enough to undergo the procedure, be willing to follow postoperative restrictions, and be willing to participate in a supervised physical therapy regimen. Exclusion criteria included patients who had a rotator cuff tear that prevented TSA, those with rotator cuff tear arthropathy, prior TSA, prior hemiarthroplasty, prior humeral or glenoid resurfacing, those not in sufficient health to undergo surgery, or those unwilling to complete appropriate follow-up and postoperative rehabilitation.

Radiographic Imaging {#section2-2325967120932106}
--------------------

All patients undergoing surgery had preoperative computed tomography scans as well as preoperative and postoperative radiographs of the involved shoulder, including standard anteroposterior, axillary lateral, and scapular lateral views. Glenoid version was measured on preoperative radiographs by 3 independent viewers with different levels of training (1 sports orthopaedic surgery fellow \[C.G.Z.\]) and 2 second-year orthopaedic surgery residents \[S.J.L., D.N.R.\]). Magnetic resonance imaging was performed to ensure integrity of the rotator cuff preoperatively.

Clinical Outcome Measures {#section3-2325967120932106}
-------------------------

American Shoulder and Elbow Surgeons (ASES), Simple Shoulder Test (SST), and visual analog scale (VAS) pain scores were collected preoperatively and at final follow-up.^[@bibr25-2325967120932106],[@bibr32-2325967120932106]^ Moreover, shoulder range of motion consisting of active forward elevation, abduction, and external rotation was recorded preoperatively and at final follow-up. To determine the clinical relevance of ASES scores, the minimal clinically important difference (MCID), the substantial clinical benefit (SCB), and the patient acceptable symptomatic state (PASS) were used.^[@bibr16-2325967120932106],[@bibr20-2325967120932106]^ The MCID and SCB were used to quantify the clinical significance of a change in scores on an outcome measure.^[@bibr20-2325967120932106]^ The PASS was used as a threshold score associated with patient satisfaction.^[@bibr20-2325967120932106]^ The MCID and SCB have been developed in shoulder arthroplasty and rotator cuff tear populations.^[@bibr8-2325967120932106],[@bibr16-2325967120932106]^ The SCB of the ASES score for TSA was a 20.7-point change, the PASS was an 81.9-point change, and the MCID was a 9.1-point change.^[@bibr16-2325967120932106]^

Surgical Technique {#section4-2325967120932106}
------------------

A standard deltopectoral approach was used to perform surgery. The subscapularis was peeled off the lesser tuberosity. After dislocation of the proximal humerus, the rotator cuff was inspected to ensure the maintenance of integrity. The anatomic neck of the proximal humerus was identified by removing all osteophytes to allow visualization of the native anatomy. The anatomic neck was then marked, and a cut was made using an oscillating saw according to the patient's anatomic version. Next, the glenoid was exposed, the labrum circumferentially removed in a 360° fashion, and the center marked under direct visualization. A glenoid guide was then used (Arthrex), and with a center pin set, minimal reaming was performed, taking care not to violate subchondral bone. The glenoid was prepared for an all-polyethylene keeled glenoid and then cemented into position. Attention was returned to the proximal humerus, which was reamed and broached, and a press-fit stem (Arthrex) was placed. Reduction was performed, final adjustments to version and inclination were made, and the humeral head was impacted into position. Subsequently, the subscapularis was repaired through bony tunnels in the proximal humerus, followed by closure of the wound. Before leaving the operating room, an abduction sling (Corflex) was placed.

Postoperatively, all patients wore a sling for 6 weeks. Physical therapy was started on postoperative day 1 while the patient was still in hospital. The primary restriction was external rotation based on the integrity of subscapularis repair intraoperatively. Additionally, all patients followed the same postoperative rehabilitation protocol, with an emphasis on range of motion and progressive strengthening.

Statistical Analysis {#section5-2325967120932106}
--------------------

Descriptive statistics to characterize differences between groups were reported using mean and standard deviation, range, or proportion, where appropriate. Mixed-effects regression was used to account for the 3 patients who contributed data for both the left and right sides. Differences in the amount of improvement between preoperative and postoperative time points were compared between the dominant and nondominant sides.

The change in the ASES score from preoperatively to postoperatively was used to determine which patients crossed the MCID and SCB thresholds. The final postoperative ASES score was used to determine whether patients met criteria for the PASS. Differences in the magnitude of improvement (absolute difference between preoperatively and postoperatively) and final postoperative clinical outcome scores were examined with an independent *t* test.

The intraclass correlation coefficient (ICC) was calculated to determine the reproducibility of glenoid version measurements by the 3 reviewers. A *P* value of \<.05 was considered statistically significant. All statistical analyses were performed using Stata 12 (StataCorp).

Results {#section6-2325967120932106}
=======

During this data collection period, 40 patients (44 shoulders) with a mean age of 69.0 ± 7.3 years (range, 58-84 years) met eligibility criteria and underwent primary TSA at the senior surgeon's institution. A total of 15 male and 25 female patients were included. The left shoulder was affected in 52.3% (n = 23) and the right shoulder in 47.7% (n = 21). There were 22 arthroplasty procedures on the dominant arm (50.0%) and 22 arthroplasty procedures on the nondominant arm (50.0%). There were 19 right hand--dominant patients. Postoperative outcomes at final follow-up were available for 42 of the 44 shoulders (95.5%). The mean follow-up period was 36.5 ± 16.2 months (range, 10-68 months).

Adequate preoperative radiographs for glenoid version measurements were available for 42 shoulders (95.5%). The mean preoperative retroversion for the dominant group was 20.8° ± 8.4° (range, 3°-40°) compared with 17.7° ± 7.1° (range, 2°-35°) for the nondominant group ([Table 1](#table1-2325967120932106){ref-type="table"}). There was no statistically significant difference between these 2 groups (*P* = .22). The ICC for measuring glenoid version was found to be 0.87.

###### 

Demographics, Clinical Outcome Scores, and Range of Motion for Patient Dominance*^a^*

![](10.1177_2325967120932106-table1)

                                      Dominant       Nondominant    *P*
  ----------------------------------- -------------- -------------- -----
  Age, y                              69.8 ± 7.2     69.2 ± 7.3     .82
  Preoperative                                                      
   Forward elevation, deg             87.9 ± 24.2    89.5 ± 17.3    .96
   Abduction, deg                     85.3 ± 27.6    87.5 ± 19.7    .83
   External rotation, deg             8.5 ± 17.8     6.5 ± 8.1      .73
   VAS score                          6.4 ± 2.4      6.5 ± 2.0      .90
   ASES score                         33.8 ± 21.7    32.9 ± 15.2    .82
   SST score                          2.4 ± 2.7      2.1 ± 1.3      .83
  Postoperative                                                     
   Forward elevation, deg             151.2 ± 28.3   138.1 ± 41.3   .42
   Abduction, deg                     142.7 ± 33.1   134.1 ± 45.9   .68
   External rotation, deg             52.2 ± 17.3    49.7 ± 22.7    .68
   VAS score                          2.4 ± 3.3      1.8 ± 3.1      .76
   ASES score                         77.3 ± 24.0    78.8 ± 29.5    .96
   SST score                          8.8 ± 2.9      8.4 ± 3.6      .94
  Preoperative glenoid version, deg   20.8 ± 8.4     17.7 ± 7.1     .22

*^a^*Data are shown as mean ± SD. ASES, American Shoulder and Elbow Surgeons; SST, Simple Shoulder Test; VAS, visual analog scale.

Overall, 89% of patients achieved the MCID, 64% achieved the SCB, and 60% reached or exceeded the PASS for the ASES score ([Figure 1](#fig1-2325967120932106){ref-type="fig"}). When comparing outcomes of TSA on the dominant versus nondominant sides, there was no statistically significant difference in the percentage of patients meeting the MCID (85% vs 93%, respectively; *P* = .58), SCB (54% vs 73%, respectively; *P* = .43), or PASS (50% vs 71%, respectively; *P* = .30) thresholds ([Figure 2](#fig2-2325967120932106){ref-type="fig"}). Similarly, when comparing outcomes from the left versus right shoulders, there was no significant difference in the percentage of patients meeting the MCID (94% vs 81%, respectively; *P* = .54), SCB (76% vs 45%, respectively; *P* = .13), or PASS (63% vs 56%, respectively; *P* = .74) thresholds ([Figure 2](#fig2-2325967120932106){ref-type="fig"}).

![Percentage of patients after total shoulder arthroplasty (TSA) who met the minimal clinically important difference (MCID), substantial clinical benefit (SCB), and patient acceptable symptom state (PASS) thresholds for the American Shoulder and Elbow Surgeons (ASES) score.](10.1177_2325967120932106-fig1){#fig1-2325967120932106}

![Percentage of patients after total shoulder arthroplasty (dominant vs nondominant, left vs right shoulder) who met the minimal clinically important difference (MCID), substantial clinical benefit (SCB), and patient acceptable symptom state (PASS) thresholds for the American Shoulder and Elbow Surgeons (ASES) score.](10.1177_2325967120932106-fig2){#fig2-2325967120932106}

Additionally, for all patients there was a significant improvement in all secondary outcome measures from preoperatively to final follow-up. The ASES score improved from 33.3 ± 18.1 preoperatively to 78.1 ± 26.4 postoperatively, the SST score improved from 2.3 ± 2.1 preoperatively to 8.6 ± 3.2 postoperatively, and the VAS score improved from 6.4 ± 2.2 preoperatively to 2.1 ± 3.2 postoperatively (*P* \< .01 for all) ([Table 2](#table2-2325967120932106){ref-type="table"} and [Figure 3](#fig3-2325967120932106){ref-type="fig"}). Further, for all patients there was a significant improvement in active range of motion from preoperatively to postoperatively. Active forward elevation improved from 88.8 ± 20.5 preoperatively to 144.4 ± 35.7 postoperatively, active abduction improved from 86.5 ± 23.4 preoperatively to 138.1 ± 40.0 postoperatively, and active external rotation improved from 7.4 ± 13.3 preoperatively to 51.0 ± 19.9 postoperatively (*P* \< .01 for all) ([Table 2](#table2-2325967120932106){ref-type="table"} and [Figure 4](#fig4-2325967120932106){ref-type="fig"}).

###### 

Postoperative and Change in Clinical Outcome Scores and Range of Motion*^a^*

![](10.1177_2325967120932106-table2)

                           Postoperative   *P*     Change From Pre- to Postoperative
  ------------------------ --------------- ------- -----------------------------------
  ASES score               78.1 ± 26.4     \<.01   44.8 ± 6.3 (34.5 to 60.1)
  VAS score                2.1 ± 3.2       \<.01   --4.3 ± 0.8 (--6.4 to --3.2)
  SST score                8.6 ± 3.2       \<.01   6.3 ± 0.7 (5.0 to 7.9)
  Forward elevation, deg   144.4 ± 35.7    \<.01   55.6 ± 8.1 (33.2 to 64.2)
  Abduction, deg           138.1 ± 40.0    \<.01   51.6 ± 5.7 (27.8 to 65.5)
  External rotation, deg   51.0 ± 19.9     \<.01   43.6 ± 9.5 (32.6 to 53.8)

*^a^*Data are shown as mean ± SD, with 95% CIs in parentheses. ASES, American Shoulder and Elbow Surgeons; SST, Simple Shoulder Test; VAS, visual analog scale.

![Preoperative and postoperative clinical outcome scores at final follow-up for all patients undergoing total shoulder arthroplasty (TSA). \*Significant improvement (*P* \< .01) compared with preoperatively. ASES, American Shoulder and Elbow Surgeons; SST, Simple Shoulder Test.](10.1177_2325967120932106-fig3){#fig3-2325967120932106}

![Preoperative and postoperative active range of motion at final follow-up for all patients undergoing total shoulder arthroplasty. \*Significant improvement (*P* \< .01) compared with preoperatively. ABD, abduction; ER, external rotation; FE, forward elevation; ROM, range of motion; TSA, total shoulder arthroplasty.](10.1177_2325967120932106-fig4){#fig4-2325967120932106}

Comparing the dominant and nondominant groups, there was no statistically significant difference in postoperative forward elevation (*P* = .42), abduction (*P* = .68), or external rotation (*P* = .68) ([Table 1](#table1-2325967120932106){ref-type="table"}). Moreover, postoperative ASES, SST, and VAS scores showed no significant difference when comparing both groups (*P* = .96, .94, and .76, respectively). For the subset of right-handed patients operated on by the right-handed surgeon, no significant difference was found in outcomes and range of motion TSA performed on the right shoulder versus the left ([Table 3](#table3-2325967120932106){ref-type="table"}).

###### 

Demographics, Clinical Outcome Scores, and Range of Motion for Shoulder Affecteda*^a^*

![](10.1177_2325967120932106-table3)

                                      Right Shoulder (n = 21)   Left Shoulder (n = 23)   *P*
  ----------------------------------- ------------------------- ------------------------ -----
  Age, y                              68.6 ± 6.6                70.2 ± 7.6               .48
  Preoperative                                                                           
   Forward elevation, deg             88.3 ± 25.8               89.1 ± 16.6              .76
   Abduction, deg                     86.0 ± 29.2               86.8 ± 19.1              .90
   External rotation, deg             9.0 ± 18.9                6.4 ± 7.9                .76
   VAS score                          6.1 ± 2.5                 6.6 ± 2.0                .54
   ASES score                         36.6 ± 21.5               31.1 ± 15.7              .35
   SST score                          2.6 ± 2.9                 2.0 ± 1.2                .78
  Postoperative                                                                          
   Forward elevation, deg             148.7 ± 29.0              141.2 ± 40.5             .76
   Abduction, deg                     139.2 ± 33.8              137.4 ± 44.6             .96
   External rotation, deg             52.8 ± 18.3               49.5 ± 21.5              .74
   VAS score                          2.4 ± 3.4                 1.9 ± 3.0                .83
   ASES score                         77.0 ± 25.5               78.9 ± 27.9              .77
   SST score                          8.7 ± 3.0                 8.5 ± 3.4                .96
  Preoperative glenoid version, deg   21.1 ± 8.9                17.8 ± 6.8               .21

*^a^*Data are shown as mean ± SD. ASES, American Shoulder and Elbow Surgeons; SST, Simple Shoulder Test; VAS, visual analog scale.

Discussion {#section7-2325967120932106}
==========

The most important finding of the present study was that the handedness of the surgeon and upper extremity dominance of patients were not found to have a significant influence on clinical outcomes after primary TSA at short-term follow-up. Patient age at the time of surgery, postoperative range of motion, and clinical scores, as they pertain to patient satisfaction reported in this study, were similar to those of prior investigations.^[@bibr31-2325967120932106]^ Additionally, the present study found that 64% of patients reached the SCB threshold for the ASES score while only 60% of patients met the PASS criteria.

Although hand dominance is known to have an impact in shoulder injuries, such as rotator cuff tears and anterior glenohumeral instability, little is known regarding the role of hand dominance after TSA.^[@bibr11-2325967120932106],[@bibr23-2325967120932106]^ Cvetanovich et al^[@bibr7-2325967120932106]^ showed greater postoperative range of motion in patients who underwent TSA of their dominant upper extremity compared with patients who had undergone TSA of their nondominant upper extremity. However, there was no significant difference in functional outcomes between both groups, which was the result found in the current study. Despite almost identical preoperative range of motion in forward elevation and abduction in both groups, final postoperative forward elevation and abduction were both greater in the dominant group, as was the amount of overall change in motion from preoperatively to postoperatively. This, however, did not reach statistical significance, a finding that may be secondary to the small sample size in the groups compared. Moreover, preoperative external rotation was greater in the dominant group, which is in agreement with prior studies assessing range of motion and handedness.^[@bibr1-2325967120932106],[@bibr6-2325967120932106],[@bibr34-2325967120932106]^

TSA has been reported to provide good to excellent results in more than 95% of patients, with an improvement in range of motion, low rates of surgical complications, more than 90% implant survivorship at 15 years, and high rates of patient satisfaction.^[@bibr1-2325967120932106],[@bibr2-2325967120932106],[@bibr5-2325967120932106],[@bibr6-2325967120932106],[@bibr9-2325967120932106],[@bibr12-2325967120932106][@bibr13-2325967120932106]--[@bibr14-2325967120932106],[@bibr18-2325967120932106]^ However, there is limited literature regarding patient-specific factors and their influence on clinical outcomes after TSA. Collin et al^[@bibr5-2325967120932106]^ showed significantly greater radiolucency in dominant extremity glenoid components compared with nondominant extremity components at 10-year follow-up, with radiographic glenoid loosening having a significant detrimental impact on shoulder function. In addition, younger age at the time of surgery and male sex have been reported to have a significantly negative impact on implant survivorship and an increased revision rate.^[@bibr4-2325967120932106],[@bibr5-2325967120932106],[@bibr13-2325967120932106]^

Extremity dominance is an important consideration in shoulder replacement surgery. Preferential use of the dominant extremity has different underlying consequences, including neurological asymmetries in the motor cortex and cervical spinal pathways.^[@bibr22-2325967120932106],[@bibr29-2325967120932106],[@bibr36-2325967120932106],[@bibr38-2325967120932106]^ In handedness-related research on the electromyographic activity of muscles affected by the glenohumeral joint, reduced muscle activity on the dominant side during abduction has been shown to correlate with reduced energy consumption and dominance-related advantages in arm dynamics.^[@bibr10-2325967120932106]^ Similarly, ballistic activities and dynamic abduction in the scapular plane are characteristic of dominant-arm tasks.^[@bibr10-2325967120932106],[@bibr21-2325967120932106]^ Thus, preferential use of the dominant extremity may promote increased wear on glenohumeral implants.^[@bibr5-2325967120932106]^

With respect to surgeon upper extremity dominance, we hypothesized that right-handed patients undergoing TSA on their right extremity would be at a higher risk for poor outcomes when operated on by a right-handed surgeon. Thus, a right-handed patient undergoing left TSA would potentially have a lower risk of adverse outcomes by minimizing the technical difficulty faced by a right-handed surgeon as well as by avoiding the potential for increased radiographic loosening.^[@bibr5-2325967120932106]^ However, among the right-handed patients operated on by the right-handed senior surgeon, there was no significant difference in functional outcomes between those who underwent right TSA and between those who underwent left TSA. In contrast, LeBlanc et al^[@bibr24-2325967120932106]^ reported worse clinical outcomes in patients who underwent hemiarthroplasty for the treatment of a proximal humerus fracture of their dominant side compared with patients with involvement of their nondominant side. Pennington et al^[@bibr28-2325967120932106]^ concluded that surgeon handedness influenced acetabular component positioning during total hip replacement. Mehta and Lotke^[@bibr26-2325967120932106]^ showed that right-hand dominance of the surgeon resulted in significantly higher clinical outcome scores in patients undergoing total knee arthroplasty on their right knee compared with patients undergoing surgery on their left knee. To our knowledge, the current study is the first to report the influence of both patient and surgeon upper extremity dominance on clinical outcomes after TSA.

There were several limitations to the study. Although data were collected prospectively, the chart review was performed retrospectively, which could create selection bias. Second, the sample size of 44 shoulders was limited, as only patients with severe glenohumeral osteoarthritis and an intact rotator cuff were included in the study, thus raising the question of whether a larger patient population would have provided a more conclusive statistical analysis. As no studies have investigated the effect of upper extremity dominance on clinical outcomes in TSA so far, only a post hoc power analysis could be performed. To assess the impact of our results on future studies, we conducted sample size calculations using our data. With 80% power at an alpha level of .05, sample sizes required for variables evaluated in this study were approximated to range well over 60 to 91 per group. The large sample sizes needed affected to a degree the small, clinically irrelevant differences observed between the groups. Of note, the sample size estimation for postoperative forward elevation by hand dominance (60 per group) was substantially lower than the other variables. The difference in postoperative forward elevation of 13.1 favoring dominant-handed patients may be clinically meaningful, prompting increased attention toward a potential type II error. This may also reflect the preferential use of the dominant extremity and greater patient motivation to regain motion of the dominant extremity postoperatively.

In addition, with this study only reporting on outcomes of a single surgeon's practice, external validity may be limited in terms of both the patient population and the surgical technique. Last, this study was limited to its short mean follow-up period of 36.5 months. However, complications or poorer outcomes related to surgeon handedness may also occur at short-term follow-up. Yet, as the initial hypothesis was rejected, longer term follow-up periods are required to adequately investigate functional outcomes as affected by surgeon handedness. However, outcomes or complications at long-term follow-up may also be influenced by complex secondary findings such as prosthesis design (survival rate), patients' compliance, or glenoid abrasive wear.

Conclusion {#section8-2325967120932106}
==========

With the numbers available, surgeon and patient upper extremity dominance did not have a significant influence on functional outcomes after primary TSA with regard to patient-reported clinical scores and range of motion at short-term follow-up.
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